Filter
156
Filtered Results: 156
Text search:
EMA
European
Medicines
Agency
Featured
Recommendations
18
New Publications
34
Language
Document type
No document type
56
Guidelines
43
Studies & Reports
25
Fact sheets
21
Manuals
6
Situation Updates
2
Strategic & Response Plan
2
Training Material
1
Countries / Regions
Germany
7
Western and Central Europe
5
Colombia
3
Africa
3
West and Central Africa
3
East and Southern Africa
2
Eastern Europe
2
Brazil
2
Tajikistan
1
Nepal
1
Thailand
1
Kenya
1
Ukraine
1
Sierra Leone
1
Chile
1
Peru
1
Philippines
1
Guinea
1
Cambodia
1
Venezuela
1
Latin America and the Carribbean
1
Congo, Democratic Republic of
1
Paraguay
1
Denmark
1
Spain
1
Argentina
1
Bangladesh
1
Uganda
1
Russia
1
Ethiopia
1
Zambia
1
Indonesia
1
Liberia
1
Ecuador
1
India
1
Authors & Publishers
Publication Years
Category
COVID-19
19
Guidelines
16
Hepatitis
10
Reproductive Health
5
Pediatrics
4
Drugs & Medical Equipment
4
HIV & STI
4
Pharmacy & Technologies
4
TB
4
MPOX - Monkeypox
3
Malaria
3
Hemorrhagic Fever
2
Medical Devices & Equipment
2
Information, Education and Communication (IEC)
2
Communicable Diseases
1
Paediatrics
1
Family Planning
1
Pharmacy & Technology
1
Buruli Ulcer
1
Diabetes
1
x MEDBOX Issue Brief & Annual Reports x
1
Cancer Treatment & Resources
1
Virology
1
Policies & Guidelines HIV & TB
1
Policies
1
Studies & Reports
1
Capacity Building
1
Humanitarian Crisis
1
Immunization
1
General Guidelines
1
Communicable Diseases
1
Neurology & Psychology
1
Human African Trypanosomiasis
1
Neonatal Care
1
Toolboxes
Country specific documents
13
Clinical Guidelines
12
Studies
7
Clinical Aspects, Treatment & Prevention
5
Drug resistant TB
5
Antiretroviral Treatment ART
5
Treatment & Prevention
4
Research
4
Communication Material
4
Immunization Guidelines
4
Vaxzevria (Astra Zeneca)
4
Assessment
4
Agriculture & Veterinary
3
International
3
Health Personnel
3
General
3
For Health Worker
3
MPOX - Monkeypox
3
General Public
3
Preparedness & Prevention
3
Drugs
2
Children & Adolescents
2
Substance Use Disorders, Others
2
Hepatitis
2
General Studies & Reports
2
Treatment Guidelines
2
Vaccine Hesitancy & Myths
2
Research & Pipeline
2
Essential Medicines
2
Supply Chain & Store Management
2
Rational use of Medicine
2
Pharmacovigilance
2
Mental Disorders
2
Antimicrobial Resistance (AMR)
2
MPOX -Monkeybox Prevention & Control
2
Clinical Aspects & Diagnostics
2
Substance Use Disorders & Addiction
2
Research & Access
2
Clinical Guidelines
2
Eastern Europe & Central Asia
2
Reports & Studies
2
Cocaine
1
Assessment & Studies
1
Surveillance
1
Childhood TB
1
Children with Disabilities
1
Ebola Prevention & Control
1
Europe
1
Prevention & Control
1
Vaccination
1
Adults
1
Opportunistic Infections
1
Policies & Programmes
1
Opoids
1
Diverse Chemical Substances
1
Global
1
Ebola
1
Children
1
Microcephaly
1
Context & Facts
1
Cannabis
1
Research & Development
1
Best Practice
1
For General Public & Community
1
Training, others
1
Clinical Guidelines
1
Scientific & Research Studies
1
Paediatrics
1
Oxygen Therapy
1
Essential Medicines & Medical Devices
1
Vaccination & Strategy
1
Access & Strategy
1
COVID-19 Vaccination
1
Logistics & Supply
1
Fair Allocation & Ethical Aspects
1
COVID-19 Vaccination Information
1
COVAX Initiative
1
Long COVID/ Post-COVID Syndrome
1
mRna Vaccines general
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Johnson & Johnson
1
Prices and Patents
1
Model Formulary
1
Pharmacy Management
1
Pharmacy Practice
1
Epilepsy
1
General Guidelines for Rational Use
1
Waste Managment
1
Reports & Studies
1
Capacity Building
1
Situation Reports & Updates
1
Guidelines & Manuals
1
Infectious Diseases
1
Water Pollution
1
MPOX - Monkeypox
1
Studies & Reports
1
Scabies
1
Global Overview
1
Alzheimer's Disease & Dementia
1
Human Rights & the Right to Health
1
Education of students & professionals
1
Roadmaps, Action Plans & Policies
1
Clinical Guidelines
1
Zika Prevention & Control
1
Tajikistan
1
Preparedness & Prevention
1
Depression
1
AMR
1
Eastern Europe and central Asia
1
В настоящем отчете (это уже четвертое его издание) анализируются препятствия и факторы, затрудняющие доступ к препаратам для лечения лекарственно-устойчивого туб...
The objective of this document is to guide the preparation and implementation of national preparedness plans for the safety of substances of human origin during outbreaks of Zika virus infection, both in affected and non-affected areas.
A survey of prevention, testing and treatment policies and practices
Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health. Submitted to the United Nations Children’s Fund by JSI, Arlington, VA: JSI Research & Training Institute, Inc....
Médecins sans Frontières access campaign
Issue Brief
Accessed: 28.11.2019
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs...
9 April 2020
WHO has published the guidance “Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected” This document is intended for clinicians taking care of hospitalized adult and paediatric patients with severe acute respiratory infection (SARI) whe...
This manual addresses all the issues. It focus on the cycle of microbes, antibiotics, vaccination, AMR,
infection prevention and control. It will support nurses on better action and also on communication towards
their patients and families.
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ...
8 March 2022
A very large number of people from Ukraine are fleeing the country and entering the European Union (EU) countries bordering Ukraine (Hungary, Poland, Romania, Slovakia) and the EU-neighbourhood country of the Republic of Moldova. Those fleeing Ukraine - mainly women and children - are ...
A One Health Response. A Briefing Note
March 2022. This report on good practices to combat AMR focuses on activities across human, animal, and environmental health in European countries. The report provides a description of practices, how they were implemented, achievements, and why the practice was unique.
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact ...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
